期刊文献+

肌氨酸氧化酶法检测尿肌氨酸的方法学性能评价及参考值分析 被引量:3

Urine sarcosine determination using sarcosine oxidase method:evaluation of methodology and assessment of reference value
下载PDF
导出
摘要 目的对肌氨酸氧化酶法检测尿肌氨酸进行方法学性能评价,初步估计尿肌氨酸的生物参考值。方法参考CLSI EP5-A2、EP17-A、EP6-A、C28-A3等文件,评价肌氨酸氧化酶法检测尿肌氨酸的重复性、空白限(limits of blank,LoB)、检测限(limitsof detection,LoD)、定量限(limits of quantitation,LoQ)、线性范围、回收率和生物参考值。结果肌氨酸氧化酶法检测2.0μmol/L肌氨酸溶液、2.9μmol/L新鲜尿液样本,总不精密度均<14.0%;肌氨酸氧化酶法检测5.0、10.0μmol/L肌氨酸溶液及6.4、9.8μmol/L新鲜尿液样本,总不精密度均<10.0%。肌氨酸氧化酶法检测尿肌氨酸的LoB约为0.35μmol/L;肌氨酸溶液的LoD、LoQ分别为1.1、1.9μmol/L,新鲜尿样本分别为1.2、2.0μmol/L;线性范围为2.0~125.6μmol/L;回收率为65.3%~90.5%。健康人群尿肌氨酸的生物参考值为0.01~0.06μmol/g肌酐。结论肌氨酸氧化酶方法检测尿肌氨酸的精密度、检测限、线性范围等可满足临床实验室的要求,但仍需在校准品基质方面有所改进以提高准确度。 Objective To evaluate the performance of sarcosine oxidase methods in the determination of urine sarcosine level and establish the biological reference range of urine sarcosine. Methods According to the documents CLSI EP5-A2, EP17-A, EPC6-A and C28-A3, the reproducibility, limit of blank (LOB), limit of detection (LoD), limit of quantitation (LoQ), linear range, recovery rate and biological reference value of the sarcosine oxidase method for determination of urine sarcosine level were evaluated. Results In the determinations for the target solution of sarcosine of 2.0 μmol/L and the fresh urine specimen with sarcosine of 2.9 μmol/L the total imprecision of the sarcosine oxidase method was less than 14.0%, while the total imprecision was less than 10.0% in the determinations for sarcosine solution of 5.0 μmol/L and 10.0 μmol/L, or fresh urine specimen with sarcosine of 6.4 μmol/L and 9.8 μmol/L. The LoB was about 0.35 μmol/L. The LOD for sarcosine solution and fresh urine specimen were 1. 1 μmol/L and 1.2 μmoL/L respectively. The LoQ for sarcosine solution and urine specimen were 1.9 μmol/L and 2.0 Ixmol/L respectively. The linear range was from 2.0 to 125.6 μmol/L, and the recovery rate was from 65.3% to 90.5%. The reference value of urine sarcosine level in healthy crowd was from 0.01 to 0. 06 μmol/g creatinine without difference in age and gender. Conclusion The precision, limits of detection and linear range of sarcosine oxidase method for detecting urine sarcosine level can meet the requirements of clinical laboratory, but the calibrator matrix should be modified to improve the accuracy of the assay.
出处 《临床检验杂志》 CAS CSCD 北大核心 2013年第6期401-405,共5页 Chinese Journal of Clinical Laboratory Science
基金 北京市自然科学基金(7112120)
关键词 肌氨酸 肌氨酸氧化酶法 性能评价 参考值 sarcosine sarcosine oxidase performance evaluation reference value
  • 相关文献

参考文献21

  • 1马妍慧,丁奕星,周韵斓,张良,陈建华,沈立松,齐隽.尿肌氨酸水平检测在前列腺癌诊断中的应用研究[J].国际检验医学杂志,2011,32(12):1299-1300. 被引量:5
  • 2Sreekumar A, Poisson LM, Rajendiran TM, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression[ J ]. Nature, 2009, 457 (7231 ) : 910-914.
  • 3Issaq H J, Veenstra TD. Is sarcosine a biomarker for prostate cancer? [J]. Sep Sci, 2011,34(24) : 3619-3621.
  • 4肖飞,刘明,王萌,等.定量检测肌氨酸的肌氨酸氧化酶方法及检测试剂盒:中国,201210429882.4[P].2012-11-01.
  • 5徐勇,张志宏.我国前列腺癌的临床热点问题探讨[J].中华泌尿外科杂志,2011,32(9):585-587. 被引量:9
  • 6Wagner MA, Joms MS. Monomeric sarcosine oxidase: 2. Kinetic studies with sarcosine, altemate substrates, and a substrate analogue [ J ]. Biochemistry, 2000, 39 (30) :8825-8829.
  • 7Wagner MA, Khanna P, Jorns MS. Structure of the flavocoenzyme of two homologous amine oxidases: monomeric sarcosine oxidase and N- methyhryptophan oxidase [ J ]. Biochemistry, 1999, 38 ( 17 ) : 5588- 5595.
  • 8Cao DL, Ye DW, Zhu Y, et al. Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algo- rithms of sarcosine in urine [ J ]. Prostate Cancer Prostatic Dis, 2011, 14(2) :166-172.
  • 9Suzuki M. Purification and some properties of sarcosine oxidase from Corynebacterium sp. U-96 [ J ]. J Biochem, 1981, 89 ( 2 ) :599-607.
  • 10Hayashi S, Nakamura S, Suzuki M. Corynebacterium sarcosine oxidase: a unique enzyme having covalently-bound and noncovalently- bound flavins[ J]. Biochem Biophys Res Commun, 1980,96 (2) : 924-930.

二级参考文献36

  • 12004年上海市市区恶性肿瘤发病率[J].肿瘤,2007,27(7):594-594. 被引量:23
  • 2Jemal A,Siegel R,Ward R,et al.Cancer statistics,2008[J].CA Cancer J Clin,2008,58(2):71-96.
  • 3Zhao Z,Shen W.Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer[J/OL].World J Surg Oncol,2004[2010-05-13].http://www.ncbi.nlm.nih.gov/pubmed/15132743.
  • 4Cavaliere B,Macchione B,Monteleone M,et al.Sarcosine as a marker in prostate cancer progression:a rapid and simple method for its quantification in human urine by solid-phase microextraction-gas chromatography-triple quadrupole mass spectrometry[J].Anal Bioanal Chem,2011,400(9):2903-2912.
  • 5Tomlins SA,Rhodes DR,Perner S,et al.Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer[J].Science,2005,310(5748):644-648.
  • 6Kumar-Sinha C,Tomlins SA,Chinnaiyan AM.Recurrent gene fusions in prostate cancer[J].Nat Rev Cancer,2008,8(7):497-511.
  • 7Narod SA,Seth A,Nam R.Fusion in the ETS gene family and prostate cancer[J].Br J Cancer,2008,99(6):847-851.
  • 8Clark J,Merson S,Jhavar S,et al.Diversity of TMPRSS2-ERG fusion transcripts in the human prostate[J].Oncogene,2007,26(18):2667-2673.
  • 9Jentzmik F,Stephan C,Miller K,et al.Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumors[J].Eur Urol,2010,58(1):12-18.
  • 10Jentzmik F,Stephan C,Lein M,et al.Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression[J].J Urol,2011,185(2):706-711.

共引文献27

同被引文献19

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部